IL6 and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study found that lower MMP9 levels and higher IL6 levels were associated with worse fibrosis by measuring 12 serum markers in 105 adult patients with NAFLD (Goyale et al., 2021).